Anand Lokare
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 10
- Emergency Medical Services top 1%
- Central Venous Catheters and Hemodialysis 2
-
- Atrial Fibrillation Management and Outcomes 5
- Hematology top 5%
- Multiple Myeloma Research and Treatments 7
-
- Chronic Lymphocytic Leukemia Research 3
-
- Protein Degradation and Inhibitors 4
-
- COVID-19 Clinical Research Studies 2
-
- Cancer Treatment and Pharmacology 2
Anand Lokare
18 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Internal Medicine 934
- Emergency Medical Services 318
- Cardiology and Cardiovascular Medicine 752
- Hematology 201
- Genetics 60
Countries citing papers authored by Anand Lokare
This map shows the geographic impact of Anand Lokare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Lokare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Lokare more than expected).
Fields of papers citing papers by Anand Lokare
This network shows the impact of papers produced by Anand Lokare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Lokare. The network helps show where Anand Lokare may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anand Lokare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 54 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 55 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 30 | |
| 13 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)breakdown → | 2018 | 855 |
| 14 | 2018 | 31 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 23 | |
| 17 | 2016 | 30 | |
| 18 | 2014 | 4 | |
| 19 | 2014 | 7 | |
| 20 | Intrapulmonary vascular dilatations with hypoxemia in extrahepatic portal vein obstruction. | 1993 | 3 |
About Anand Lokare
Anand Lokare is a scholar working on Internal Medicine, Hematology and Genetics, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (10 papers), Multiple Myeloma Research and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (5 papers), Protein Degradation and Inhibitors (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Central Venous Catheters and Hemodialysis (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Internal Medicine (934 citations), Emergency Medical Services (318 citations) and Cardiology and Cardiovascular Medicine (752 citations). Anand Lokare has collaborated with scholars based in United Kingdom, Canada and India. Frequent co-authors include Oliver Chapman, Janet Dunn, Annie Young, Catherine St. Hill, Andrea Marshall, Mark N. Levine, Danielle Hale, Richard Hobbs, Anthony Maraveyas and Stavros Petrou. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.